Douglas Hutchens
Director/Board Member presso ANIMALCARE GROUP PLC
Profilo
Presently, Douglas Eugene Hutchens holds the position of Chief Scientific Officer of Animol Discovery.
He is also on the board of Animalcare Group Plc.
Dr. Hutchens previously held the position of Chief Veterinary Officer & Executive VP at Bayer Animal Health and Assistant Professor at the University of Illinois College of Veterinary Medicine.
Dr. Hutchens received a doctorate from the University of Illinois.
Posizioni attive di Douglas Hutchens
Società | Posizione | Inizio |
---|---|---|
ANIMALCARE GROUP PLC | Director/Board Member | 10/02/2022 |
Animol Discovery
Animol Discovery Pharmaceuticals: MajorHealth Technology Animol Discovery develops small molecule drugs for animals. The company was founded by Phil Austin in 2019 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Douglas Hutchens
Società | Posizione | Fine |
---|---|---|
Crenae Therapeutics, Inc. | Director/Board Member | 01/08/2022 |
Bayer Animal Health
Bayer Animal Health Pharmaceuticals: MajorHealth Technology Bayer Animal Health provides medical healthcare for livestock. The company is headquartered in Shawnee Mission, KS. | Corporate Officer/Principal | 01/07/2020 |
University of Illinois College of Veterinary Medicine | Corporate Officer/Principal | - |
Formazione di Douglas Hutchens
University of Illinois | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ANIMALCARE GROUP PLC | Health Technology |
Aziende private | 3 |
---|---|
Bayer Animal Health
Bayer Animal Health Pharmaceuticals: MajorHealth Technology Bayer Animal Health provides medical healthcare for livestock. The company is headquartered in Shawnee Mission, KS. | Health Technology |
Animol Discovery
Animol Discovery Pharmaceuticals: MajorHealth Technology Animol Discovery develops small molecule drugs for animals. The company was founded by Phil Austin in 2019 and is headquartered in Boston, MA. | Health Technology |
Crenae Therapeutics, Inc. |